Frontlight ResearchEarly access
CompletedNo phase
TipTraQ Home Sleep Test Study, SHH
Key facts
- Who runs it
- PranaQ Pte. Ltd.
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 112 people enrolled
- Started
- 1 Mar 2023
- Ended
- 27 Mar 2024
- Type of study
- Observational
- Record updated
- 18 October 2024
Who can take part
- Age
- 20 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Subjects from the age of 20 and older that have an indication for an in-lab PSG study
Who cannot take part
- Chronic opioid medication user
- Heart transplant
- Heart failure, New Youk Heart Association (NYHA) classification III or IV
- Devastating severe strokes, with the modified Rankin score (mRS)≥4
- Tracheostomy
- Incapable of comprehending and signing the informed consent and questionnaires, including but not limited to subjects with severe Alzheimer's, unconscious by head trauma, or of someone with limited mental capacity
- Cannot correctly follow the order to use the TipTraQ device
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The clinical study aims to develop and validate the TipTraQ system, created by PranaQ, a home sleep test for sleep apnea screening. The system comprises a wearable device and a cloud-based AI for estimating Total Sleep Time (TST) and Apnea-Hypopnea Index (AHI).
The group in the trial
- Healthy or people who has indication to conduct polysomnography (PSG).
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Feasibility Evaluation of Sleep Apnea Screening with Photoplethysmography
- Publications
- Record updated
- 18 October 2024